A Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors
for Colorectal Neoplasms
21 locations incl. Phoenix
Sponsor: Seagen, a wholly owned subsidiary of Pfizer
Sex: All·Age: 18+
Code: NCT06131840·Phase 1·Recruiting
Colorectal cancer Clinical Trials in Houston, TX
As of June 2026, 59 paid clinical trials are recruiting for Colorectal cancer in Houston, Texas. Colorectal cancer trials explore novel chemotherapy combinations, targeted agents, and immunotherapy for microsatellite-instability-high tumors. Compensation typically covers time, travel, and study visits, and many studies also include study-related medical care at no cost.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Related specialties in Houston
Filter results
Filter results
59 clinical trials for Colorectal cancer
·Clear filters·↓ Download CSVStudy of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
for Non-Small Cell Lung Cancer (NSCLC)
Drug: daraxonrasib
21 locations incl. Duarte
Sponsor: Revolution Medicines, Inc.
Sex: All·Age: 18+
Code: NCT06128551·Phase 1, Phase 2·Recruiting
A Study of NT-175 in Adult Subjects With Unresectable, Advanced, and/or Metastatic Solid Tumors That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation
for Non-small Cell Lung Cancer
18 locations incl. Gilbert
Sponsor: AstraZeneca
Sex: All·Age: 18+
Code: NCT05877599·Phase 1·Recruiting
FOG-001 in Locally Advanced or Metastatic Solid Tumors
for Cancer
31 locations incl. Phoenix
Sponsor: Parabilis Medicines, Inc.
Sex: All·Age: 18+
Code: NCT05919264·Phase 1, Phase 2·Recruiting
A Phase IIa Randomized, Double-Blinded Clinical Trial of Naproxen or Aspirin for Cancer Immune Interception in Lynch Syndrome
for T Cells
1 location in Houston
Sponsor: M.D. Anderson Cancer Center
Sex: All·Age: 18+
Code: NCT05411718·Phase 2·Recruiting
Connecting Black Families in Houston, Texas to Hereditary Cancer Genetic Counseling, Genetic Testing, and Cascade Testing by Using a Simple Genetic Risk Screening Tool and Telegenetics
for Breast Cancer
1 location in Houston
Sponsor: M.D. Anderson Cancer Center
Sex: All·Age: 18+·Accepts healthy volunteers
Code: NCT05694559·Recruiting
Identifying Underserved Individuals inTexas With Hereditary Cancer Risk Using Mobile Mammography Units and Telegenetics.
for Ovarian Cancer
1 location in Houston
Sponsor: M.D. Anderson Cancer Center
Sex: Female·Age: 18+
Code: NCT05649072·Recruiting
A Study of Tucatinib With Trastuzumab and mFOLFOX6 Versus Standard of Care Treatment in First-line HER2+ Metastatic Colorectal Cancer
for Colorectal Neoplasms
128 locations incl. Glendale
Sponsor: Seagen, a wholly owned subsidiary of Pfizer
Sex: All·Age: 18+
Code: NCT05253651·Phase 3·Recruiting
Study of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)
for Endometrial Cancer
18 locations incl. Los Angeles
Sponsor: AstraZeneca
Sex: All·Age: 18 - 130
Code: NCT05489211·Phase 2·Recruiting
Anti-CEACAM5 ADC M9140 in Advanced Solid Tumors (PROCEADE-CRC-01)
for Colorectal Cancer
6 locations incl. Encinitas
Sponsor: EMD Serono Research & Development Institute, Inc.
Sex: All·Age: 18+
Code: NCT05464030·Phase 1·Recruiting
TAS-102 With or Without Celecoxib in ctDNA-defined Minimal Residual Disease in Colorectal Cancer After Completion of Adjuvant Chemotherapy
for Colorectal Cancer
1 location in Houston
Sponsor: M.D. Anderson Cancer Center
Sex: All·Age: 18+
Code: NCT05343013·Phase 2·Recruiting
Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
for Colorectal Carcinoma
21 locations incl. Birmingham
Sponsor: Children's Oncology Group
Sex: All·Age: 12 Months - 30
Code: NCT04851119·Phase 1, Phase 2·Recruiting
Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing
for Solid Tumor, Adult
16 locations incl. Gilbert
Sponsor: A2 Biotherapeutics Inc.
Sex: All·Age: 18+
Code: NCT04981119·Recruiting
Binary Oncolytic Adenovirus in Combination With HER2-Specific Autologous CAR VST, Advanced HER2 Positive Solid Tumors
for Bladder Cancer
1 location in Houston
Sponsor: Baylor College of Medicine
Sex: All·Age: 18+
Code: NCT03740256·Phase 1·Recruiting
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
for Advanced Solid Tumor
32 locations incl. Irvine
Sponsor: PMV Pharmaceuticals, Inc
Sex: All·Age: 12+
Code: NCT04585750·Phase 1, Phase 2·Recruiting
Role of Diet on the Microbiome of the Digestive System
for Colorectal Carcinoma
1 location in Houston
Sponsor: M.D. Anderson Cancer Center
Sex: All·Age: 45+
Code: NCT04666727·Recruiting
Study of Safety and Tolerability of BCA101 Monotherapy and in Combination Therapy in Patients With EGFR-driven Advanced Solid Tumors
for Head and Neck Squamous Cell Carcinoma
15 locations incl. La Jolla
Sponsor: Bicara Therapeutics
Sex: All·Age: 18+
Code: NCT04429542·Phase 1·Recruiting
Study of IDE196 in Patients With Solid Tumors Harboring GNAQ/11 Mutations or PRKC Fusions
for Metastatic Uveal Melanoma
12 locations incl. Los Angeles
Sponsor: IDEAYA Biosciences
Sex: All·Age: 18+
Code: NCT03947385·Phase 1, Phase 2·Recruiting
A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid Tumors
for Advanced/Metastatic Solid Tumors
23 locations incl. La Jolla
Sponsor: Merus B.V.
Sex: All·Age: 18+
Code: NCT03526835·Phase 1, Phase 2·Recruiting